Search

Ah Yuen Lee

from Brooklyn, NY
Age ~88
Get Report
Also known as:
Ah Y Lee, Ah Lee Lee, Ah Ylee, Lee Ah Yuen, Lee A Yuen, Ah Yuen Yuenlee, As Y Lee, Ahyuen Lee, Yuen Lee Ah
Phone and address:
181 Bay 20Th St, Brooklyn, NY 11230
(718) 265-9696
Related to:
Wai S Tien, 55Yan Keong Lee, 63Janet Lee, 54Stella Lee, 46Lan H Lee, 52Wai M Lee, 54Howard W Curtis, 75Sook Ching Lee, 46Mun W Chee, 63Janet Lee, 54Wai Leong Lee, 56
Connected to:
A Lee, 45Abi A Lee, 31Abigail LeeAbu B Lee, 66Adela C Lee, 64Adelyn S Lee, 39Adrian J Lee, 36Adriane C Lee, 57Aen H Lee, 44Aeren Lee, 33

Ah Lee Phones & Addresses

  • 181 Bay 20Th St, Brooklyn, NY 11230 (718) 265-9696 (718) 265-2712
  • 56 Henry St, New York, NY 10002 (212) 349-8714
  • 165 Henry St, New York, NY 10002
  • Staten Island, NY
  • Shrub Oak, NY
  • Bronx, NY

Resumes

Resumes

Ah Lee Photo 1

Registered Nurse

View page
Location:
Bayside, NY
Industry:
Hospital & Health Care
Work:
St Francis Hospital
Registered Nurse
Ophthalmic Consultants of Long Island
Ophthalmic Scribe
Binghamton University Sep 2011 - Dec 2012
Undergraduate Teaching Assistant
Genji Japanese Cuisine Apr 2008 - Aug 2010
Cashier
Education:
New York University 2017 - 2018
Bachelors, Bachelor of Science, Nursing Binghamton University 2009 - 2013
Bachelors, Bachelor of Arts, Chemistry Bayside High School 2005 - 2009
Skills:
Microsoft Office
Microsoft Excel
Powerpoint
Gc Ms
Gas Chromatography
Hplc
Cyclic Voltammetry
Autotitrator
Potentiometry
Ir Spectroscopy
Pcr
Fluorescence Spectrophotometry
Atomic Spectroscopy
Interests:
Health
Languages:
English
Korean
Certifications:
Basic Life Support (Bls)
Advanced Cardiovascular Life Support (Acls)
Pediatric Advanced Life Support
Ah Lee Photo 2

Sales Associate

View page
Location:
Brooklyn, NY
Work:
Dunkin Donuts
Sales Associate
Ah Lee Photo 3

Accompanist

View page
Location:
New York, NY
Industry:
Music
Work:
Richmond Choral Society
Accompanist
Queens Summer Vocal Institute
Pianist and Vocal Coach
College of Staten Island, City University of New York
Adjunct Lecturer
Education:
Sangmyung University
Bachelors, Music, Piano New York University
Masters, Music, Multimedia, Film
Skills:
Pianist
Vocal
Research
Composition
Piano
Teaching
Band
Sound
Accompaniment
Songs
Jazz
Higher Education
Musical Theatre
Bands
Singing
Music
Music Education
Music Composition
Ah Lee Photo 4

Ah Lee

View page
Ah Lee Photo 5

Ah Lee

View page

Business Records

Name / Title
Company / Classification
Phones & Addresses
Ah C. Lee
Owner
Pak Car Boutique Corp
Ret Auto/Home Supplies
212 Canal St, New York, NY 10013
(212) 962-6931
Ah Run Lee
BOWERY ELECTRONICS CENTER INC
133 Bowery, New York, NY 10002
Ah Pun Lee
18TH AVE ELECTRONICS INC
Retail · Home Theater Design
6302 18 Ave, Brooklyn, NY 11204
(718) 236-3632
Ah Pun Lee
BOWERY APPLIANCE INC
144 Bowery St, New York, NY 10013
144 Bowery, New York, NY 10013
Ah Lol Lee
G CONSTRUCTION GROUP INC
133-12 41 Rd #1R, Flushing, NY 11355
41-61 150 St, Flushing, NY 11355
Ah Chui Lee
LEEREN BEAUTY SALON INC
104 Forsyth St, New York, NY 10002
Ah Pan Lee
AV CENTER, INC
65 E Broadway, New York, NY 10002
Ah P. Lee
Vice-President
AVC ENTERPRISE INC
Ret Appliances
298 Grand St, New York, NY 10002
(212) 431-1592

Publications

Us Patents

Sumoylation Of Serca2A And Cardiovascular Disease

View page
US Patent:
20190060424, Feb 28, 2019
Filed:
Sep 4, 2018
Appl. No.:
16/121273
Inventors:
- New York NY, US
Chang Won Kho - New York NY, US
Ah Young Lee - New York NY, US
International Classification:
A61K 38/50
C12Q 1/6883
C12N 7/00
C12N 15/86
A61K 48/00
A61K 38/17
A61K 31/7088
G01N 33/573
Abstract:
Methods for treating cardiovascular disease, and in particular heart failure, are provided comprising administering a therapeutically effective amount of a modulator of SERCA2a post-translation modification such as SUMOylation or acetylation. Also provided are methods of treating cardiovascular disease by inhibiting SERCA2a degradation. Further provided are methods of diagnosing a propensity to develop heart failure comprising determining if a SERCA2a mutant is present or determining the level of expression of SUMO1 in cardiomyocytes. The disclosure also provides methods of screening for therapeutics that modulate the post-translational modification of SERCA2a, such as by modulating post-translational SUMOylation and/or acetylation.

Benzothiazole Or Benzoxazole Compounds As Sumo Activators

View page
US Patent:
20180127407, May 10, 2018
Filed:
Nov 29, 2017
Appl. No.:
15/826238
Inventors:
- New York NY, US
Ah Young Lee - New York NY, US
Changwon Kho - New York NY, US
Roger J. Hajjar - Tenafly NJ, US
International Classification:
C07D 417/12
C07D 413/12
A61K 48/00
A61K 31/4245
C07D 413/04
A61K 31/433
A61K 31/428
Abstract:
Provided are SUMO activators, which can enhance SUMOylation of SERCA2a, which are useful in the treatment of heart failure, cardiovascular diseases, cancer, neurodegenerative disorders, viral infection, bacterial infection, liver disease, inflammation, and other diseases.

Sumoylation Of Serca2A And Cardiovascular Disease

View page
US Patent:
20170014494, Jan 19, 2017
Filed:
Sep 30, 2016
Appl. No.:
15/281269
Inventors:
- New York NY, US
Chang Won Kho - New York NY, US
Ah Young Lee - New York NY, US
International Classification:
A61K 38/50
A61K 48/00
C12Q 1/68
C12N 7/00
G01N 33/573
A61K 38/17
C12N 15/86
Abstract:
Methods for treating cardiovascular disease, and in particular heart failure, are provided comprising administering a therapeutically effective amount of a modulator of SERCA2a post-translation modification such as SUMOylation or acetylation. Also provided are methods of treating cardiovascular disease by inhibiting SERCA2a degradation. Further provided are methods of diagnosing a propensity to develop heart failure comprising determining if a SERCA2a mutant is present or determining the level of expression of SUMO1 in cardiomyocytes. The disclosure also provides methods of screening for therapeutics that modulate the post-translational modification of SERCA2a, such as by modulating post-translational SUMOylation and/or acetylation.

Sumoylation Of Serca2A And Cardiovascular Disease

View page
US Patent:
20150316551, Nov 5, 2015
Filed:
Jul 13, 2015
Appl. No.:
14/798357
Inventors:
Roger Joseph Hajjar - Tenafly NJ, US
Chang Won Kho - New York NY, US
Ah Young Lee - New York NY, US
Assignee:
Icahn School of Medicine at Mount Sinai - New York NY
International Classification:
G01N 33/573
C12Q 1/68
Abstract:
Methods for treating cardiovascular disease, and in particular heart failure, are provided comprising administering a therapeutically effective amount of a modulator of SERCA2a post-translation modification such as SUMOylation or acetylation. Also provided are methods of treating cardiovascular disease by inhibiting SERCA2a degradation. Further provided are methods of diagnosing a propensity to develop heart failure comprising determining if a SERCA2a mutant is present or determining the level of expression of SUMO1 in cardiomyocytes. The disclosure also provides methods of screening for therapeutics that modulate the post-translational modification of SERCA2a, such as by modulating post-translational SUMOylation and/or acetylation.

Benzothiazole Or Benzoxazole Compounds As Sumo Activators

View page
US Patent:
20150218148, Aug 6, 2015
Filed:
Aug 29, 2013
Appl. No.:
14/424289
Inventors:
- New York NY, US
Ah Young Lee - New York NY, US
Changwon Kho - New York NY, US
Roger J. Hajjar - Tenafly NJ, US
International Classification:
C07D 417/12
A61K 48/00
A61K 31/4245
C07D 413/12
A61K 31/428
A61K 31/433
Abstract:
Provided are SUMO activators, which can enhance SUMOylation of SERCA2a, which are useful in the treatment of heart failure, cardiovascular diseases, cancer, neurodegenerative disorders, viral infection, bacterial infection, liver disease, inflammation, and other diseases.

Sumoylation Of Serca2A And Cardiovascular Disease

View page
US Patent:
20140234287, Aug 21, 2014
Filed:
Jul 13, 2012
Appl. No.:
14/232105
Inventors:
Roger Joseph Hajjar - Tenafly NJ, US
Chang Won Kho - New York NY, US
Ah Young Lee - New York NY, US
Assignee:
Icahn School of Medicine at Mount Sinai - New York NY
International Classification:
A61K 38/50
G01N 33/573
C12Q 1/68
A61K 38/17
US Classification:
424 946, 514 44 R, 435 76, 435 618, 435 61, 435 613
Abstract:
Methods for treating cardiovascular disease, and in particular heart failure, are provided comprising administering a therapeutically effective amount of a modulator of SERCA2a post-translation modification such as SUMOylation or acetylation. Also provided are methods of treating cardiovascular disease by inhibiting SERCA2a degradation. Further provided are methods of diagnosing a propensity to develop heart failure comprising determining if a SERCA2a mutant is present or determining the level of expression of SUMO1 in cardiomyocytes. The disclosure also provides methods of screening for therapeutics that modulate the post-translational modification of SERCA2a, such as by modulating post-translational SUMOylation and/or acetylation.
Control profile
Ah Yuen Lee from Brooklyn, NY, age ~88 Get Report